Home  |  Contact

Cellosaurus PER.C6 (CVCL_G704)

[Text version]

Cell line name PER.C6
Synonyms PER C6; PERC6; PER cell clone 6
Accession CVCL_G704
Resource Identification Initiative To cite this cell line use: PER.C6 (RRID:CVCL_G704)
Comments Group: Vaccine production cell line.
Registration: International Depositary Authority, European Collection of Cell Cultures (ECACC); 96022940.
Transformant: NCBI_TaxID; 28285; Adenovirus 5 [E1A/E1B].
Species of origin Homo sapiens (Human) (NCBI Taxonomy: 9606)
Originate from same individual CVCL_1K15 ! 911
Age at sampling Fetus
Category Transformed cell line
Web pages https://web.archive.org/web/20140721200546/http://www.crucell.com/page/downloads/Factsheet_PER.C6_Technology.pdf
https://web.archive.org/web/20121219090924/http://www.dsm.com/en_US/downloads/dpp/PER.C6_Brochure.pdf
http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/p/cell-lines-detail-452.html
Publications

PubMed=9741429; DOI=10.1089/hum.1998.9.13-1909
Fallaux F.J., Bout A., van der Velde I., van den Wollenberg D.J.M., Hehir K.M., Keegan J., Auger C., Cramer S.J., van Ormondt H., van der Eb A.J., Valerio D., Hoeben R.C.
New helper cells and matched early region 1-deleted adenovirus vectors prevent generation of replication-competent adenoviruses.
Hum. Gene Ther. 9:1909-1917(1998)

PubMed=11257414; DOI=10.1016/S0264-410X(00)00508-9
Pau M.G., Ophorst C., Koldijk M.H., Schouten G., Mehtali M., Uytdehaag F.
The human cell line PER.C6 provides a new manufacturing system for the production of influenza vaccines.
Vaccine 19:2716-2721(2001)

Patent=US6602706
Fallaux F.J., Hoeben R.C., van der Eb A.J., Bout A., Valerio D.
Packaging systems for human recombinant adenovirus to be used in gene therapy.
Patent number US6602706, 05-Aug-2003

PubMed=16566444
Lewis J.A., Brown E.L., Duncan P.A.
Approaches to the release of a master cell bank of PER.C6 cells; a novel cell substrate for the manufacture of human vaccines.
Dev. Biol. (Basel) 123:165-176(2006)

PubMed=25903999; DOI=10.1002/biot.201400388
Genzel Y.
Designing cell lines for viral vaccine production: where do we stand?
Biotechnol. J. 10:728-740(2015)

Patent=US9469865
Zijlstra G.M., Hof R.P., Schilder J.
Process for the culturing of cells.
Patent number US9469865, 18-Oct-2016

Cross-references
Other Wikidata; Q54947225